Skip to main content
Fig. 4 | Gut Pathogens

Fig. 4

From: The effects of probiotic treatment with Bifidobacterium breve, Bif195 for small intestinal Crohn’s disease and the gut microbiome: results from a randomised, double-blind, placebo-controlled trial

Fig. 4

Relative abundance (%) of Bifidobacterium breve divided into study visits in the Bif195 and placebo groups. In the Bif195 group, Bifidobacterium breve was differentially abundant at week 8 compared to week 0 with statistical significance before adjustments for multiple testing but not after

Back to article page

Gut Pathogens

ISSN: 1757-4749